U
QGENF

UBS’s QIAGEN NV QGENF Stock Holding History

UBS’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-200
Closed -$5K – 11527
2013
Q4 		$5K Buy
200
+100
+100% +$2.5K ﹤0.01% 9665
2013
Q3 		$2K Hold
100
– – ﹤0.01% 10103
2013
Q2 		$2K Buy
+100
New +$2K ﹤0.01% 9980

Other funds holding QGENF

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

UBS's QGENF Position: Q3 2014 in Review

UBS increased its QIAGEN NV (QGENF) stake by 826% in Q3 2014, buying an estimated $4.44M and bringing the position to 218,471 shares worth $4.97M. The position accounts for ﹤0.01% of the portfolio, ranked #2040.

UBS first reported a position in QGENF in Q2 2013 and has held it in 6 quarters since. 172 funds tracked by Wall St. Rank hold QGENF as of Q3 2014.

  • UBS held 218,471 shares of QIAGEN NV worth $4.97M as of Q3 2014.
  • UBS bought 194,866 QIAGEN NV shares in Q3 2014, an estimated $4.44M.
  • QIAGEN NV made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2040 holding.
  • UBS first reported a position in QIAGEN NV in Q2 2013 and has held it in 6 quarters since.
  • 172 funds tracked by Wall St. Rank held QIAGEN NV as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.